Products
14886 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Newmont Constant Leverage with ISIN code: CH1450969436 | Newmont | Constant Leverage | Long | ― | 99.988 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | -93.75% | 15 Sep. 2025 | |
| Newmont Constant Leverage with ISIN code: CH1290992903 | Newmont | Constant Leverage | Long | ― | 99.988 | 41.12 | 0.130 | 41.25 | 1 | -0.32% | 15.09% | -69.76% | 16 Feb. 2024 | |
| Nike Constant Leverage with ISIN code: CH1362350402 | Nike | Constant Leverage | Long | ― | 52.254 | 0.35 | ― | ― | 1 | 0.00% | -5.41% | -50.70% | 12 Aug. 2024 | |
| Nokia Constant Leverage with ISIN code: CH1450970210 | Nokia | Constant Leverage | Long | ― | 7.182 | 4.89 | 0.140 | 5.03 | 1 | -2.78% | 24.43% | 31.10% | 3 Nov. 2025 | |
| Nokia Constant Leverage with ISIN code: CH1450969105 | Nokia | Constant Leverage | Long | ― | 7.182 | 62.65 | 1.800 | 64.45 | 1 | -2.79% | 24.23% | 30.93% | 21 Aug. 2025 | |
| Nokia Constant Leverage with ISIN code: CH1119067226 | Nokia | Constant Leverage | Long | ― | 7.182 | 2.68 | 0.040 | 2.72 | 1 | -1.47% | 13.56% | 28.85% | 6 May. 2022 | |
| Novartis Constant Leverage with ISIN code: CH1276587271 | Novartis | Constant Leverage | Long | ― | 118.585 | 17.16 | 0.160 | 17.32 | 1 | -0.92% | 12.30% | -28.20% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587297 | Novartis | Constant Leverage | Long | ― | 118.585 | 6.27 | 0.120 | 6.39 | 1 | -1.88% | 24.90% | -51.47% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587289 | Novartis | Constant Leverage | Long | ― | 118.585 | 12.78 | 0.160 | 12.94 | 1 | -1.24% | 18.88% | -40.36% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587305 | Novartis | Constant Leverage | Long | ― | 118.585 | 1.9 | 0.040 | 1.94 | 1 | -2.06% | 31.94% | -60.82% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416671 | Novartis | Constant Leverage | Long | ― | 118.585 | 29.21 | ― | ― | 1 | 0.00% | 42.91% | -69.36% | 12 May. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968487 | Novo Nordisk | Constant Leverage | Long | ― | 237.887 | 0.002 | ― | ― | 1 | 0.00% | 100.00% | 0.00% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 237.887 | 0.009 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993299 | Novo Nordisk | Constant Leverage | Long | ― | 237.887 | 0.009 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 11 Mar. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968479 | Novo Nordisk | Constant Leverage | Long | ― | 237.887 | 0.57 | 0.030 | 0.6 | 1 | -5.00% | -1.72% | -8.06% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968495 | Novo Nordisk | Constant Leverage | Long | ― | 237.887 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 21 Aug. 2025 | |
| Nvidia Constant Leverage with ISIN code: CH1119068000 | Nvidia | Constant Leverage | Long | ― | 172.166 | 76.11 | 0.180 | 76.29 | 1 | -0.24% | -4.91% | -15.63% | 12 May. 2022 | |
| Nvidia Constant Leverage with ISIN code: CH1217423008 | Nvidia | Constant Leverage | Long | ― | 172.166 | 3.72 | 0.020 | 3.74 | 1 | -0.53% | -9.49% | -27.77% | 4 Nov. 2022 | |
| Nvidia Constant Leverage with ISIN code: CH1246614460 | Nvidia | Constant Leverage | Long | ― | 172.166 | 0.8 | 0.010 | 0.81 | 1 | -1.23% | -10.11% | -27.27% | 3 Feb. 2023 | |
| Nvidia Constant Leverage with ISIN code: CH1290992705 | Nvidia | Constant Leverage | Long | ― | 172.166 | 0.034 | ― | ― | 1 | 0.00% | -5.56% | -19.05% | 5 Feb. 2024 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.